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Abstract: A new flow-injection spectrophotometric method for the determination of glutathione (GSH), penicillamine (PEN) and tiopronin 
(mercaptopropionyl glycine, MPG) in pharmaceutical formulations is reported. The method is based on the reduction of Cu(II)-neocuproine reagent 
to Cu(I)-neocuproine by GSH, PEN or MPG in buffered medium (pH = 3) to form a stable coloured complex (λmax = 458 nm). Experimental conditions 
were optimized by univariate method, resulting with linear calibration curves in concentration range from 2 × 10−6 to 3 × 10−5 mol L−1 for GSH,  
6 × 10−7 to 4 × 10−5 mol L−1 for PEN and 4 × 10−7 to 4 × 10−5 mol L−1 for MPG. The achieved analytical frequency was 180 h−1 for GSH and PEN and  
120 h−1 for MPG. The proposed method was successfully applied for determination of GSH, PEN and MPG in pharmaceutical formulations, and the 
usual excipients in pharmaceuticals did not interfere with the analysis. 
 





LUTATHIONE (γ-L-glutamyl-L-cysteinyl-glycine, GSH) 
is a tripeptide present in every cell of the human 
body. GSH is the most important hydrophilic antioxidant 
that protects cells against exogenous and endogenous tox-
ins, including reactive oxygen (ROS) and nitrogen (RNS) spe-
cies. Supplementation with GSH showed antiaging and 
hepatoprotective effects in humans.[1,2] Penicillamine (PEN) 
is a synthetic amino acid that contains an additional SH 
group and it is a structural component of the penicillin mol-
ecule. PEN is capable of forming nontoxic, water-soluble 
chelated compounds with heavy metals, which are then 
excreted in the urine. PEN was the first chelator used for 
Wilson’s disease and it can be also used for lead, mercury 
and arsenic poisoning.[3,4] Tiopronin (mercaptopropionyl 
glycine, MPG) is a synthetic aminothiol compound with 
reducing and complexation properties. It is used primarily 
for the treatment of cystinuria, as it increases cystine solu-
bility by a thiol-disulfide exchange with cystine to form a 
complex with the cysteine monomer, forming a highly 
soluble disulfide compound.[5,6]  
 Several methods have been reported for determina-
tion of these thiol compounds (RSH) in pure form and 
pharmaceutical formulations. The British Pharmacopoeia 
recommend redox titration for GSH[7] and MPG,[8] and acid-
base titration in non-aqueous media for PEN.[9] Other re-
ported methods for determination of these RSH in pharma-
ceuticals include spectrophotometry,[10–14] fluorimetry,[15–17] 
chemiluminescence,[18–20] electroanalytical[21–23] and chro-
matographic techniques.[24–26]  
 Flow injection analysis (FIA) became a versatile 
instrument tool for the quality control of pharmaceuticals 
in the 21st century. This results from the instrumentation 
simplicity, inexpensive determination and high throughput 
capacities.[27] FIA can be coupled to any detection system 
capable of flow-through operation, but spectrophotomet-
ric detection still takes precedence over the other detec-
tion techniques, as it offers the advantages of both 
versatility and use of simple, inexpensive instrument avail-
able in all quality control laboratories. Another significant 
advantage is that pre-existing batch instruments can be 
easily converted to flow through by either home-made or 
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 The literature is relatively limited in FIA methods 
with spectrophotometric detectors for the determination 
of GSH, PEN or MPG in pharmaceutical formulations. At the 
best of our knowledge, there are only two published 
methods for determination of PEN,[29,30] two for MPG[30,31] 
and none for GSH. 
 In this report, a new, simple, rapid and sensitive FIA 
method with spectrophotometric detector for the determi-
nation of GSH, PEN and MPG is described and validated. 
The proposed method is based on a redox reaction in which 
RSH reduces Cu(II)-neocuproine to form an orange-yellow 
Cu(I)-neocuproine complex which absorbs light at 458 nm. 
The procedure is simple, inexpensive, does not involve any 
pre-treatment procedure and has a high sample analysis 
frequency. The method was successfully applied for deter-
mination of GSH, PEN and MPG in pharmaceutical formula-
tions. In comparison with the published FIA methods, the 
proposed method has a wider linear dynamic range, higher 
sensitivity and sampling rate. 
 
EXPERIMENTAL 
Reagents and Chemicals 
All reagents and chemicals used in the present study were 
of analytical grade and were used without further purifica-
tion. Milli-Q (Millipore) deionized water was used as an ap-
propriate diluent. 
 The stock solutions of thiol compounds (RSH) {c(RSH) 
= 1.0 × 10–2 mol L–1}, glutathione (Sigma-Aldrich, St. Louis, 
Missouri, USA), penicillamine (Fluka Chemika, St. Louis, 
Missouri, USA) and tiopronin (Sigma, St. Louis, Missouri, 
USA), were prepared by dissolving the appropriate amount 
of thiol compound: 0.3073 g of GSH; 0.1492 g of PEN; 0.1632 
g of MPG; into Britton-Robinson buffer solution (pH = 2) and 
diluted to 100.0 mL volume. The prepared stock solutions 
were stored at 4 °C in dark bottles and were stable for at 
least one month. Working standards of lower concentra-
tion were daily prepared diluting the above-mentioned 
stock solutions with Britton-Robinson buffer solution (pH = 
3). 
 The Britton-Robinson buffer solution (pH ~ 2) was 
prepared by dissolving 4.94 g of boric acid (Alkaloid, Skopje, 
Macedonia), mixing with 4.79 g of glacial acetic acid (VWR 
Chemicals, France) and 5.45 g of phosphoric acid (Kemika, 
Zagreb, Croatia)  and diluting with deionised water up to 
2000 mL yielding the final concentration 4.0 × 10–2 mol L–1. 
Higher pH values were adjusted by adding sodium hydrox-
ide solution, {c(NaOH) = 2.0 mol L–1}. 
 The oxidizing solution of copper(II)-neocuproine rea-
gent was prepared by dissolving 25.0 mg of copper(II) sul-
fate pentahydrate (Kemika, Zagreb, Croatia) and 50.0 mg of 
neocuproine hydrate, (Sigma-Aldrich, St. Louis, Missouri, 
USA) {1.0 mmol L–1 Cu(II) + 2.4 mmol L–1 Nc} in 100.0 mL 
Britton-Robinson buffer solution (pH = 3). According to the 
literature neocuproine (2,9-dimethyl-1,10-phenantroline) 
is slightly soluble in water, hence its solubility is improved 
in the mixture with the Cu(II) because the complex 
copper(II)-neocuproine, (Cu(Nc)22+) is formed. Copper(II)-
neocuproine reagent was stable for at least 30 days stored 
at 4 °C. The molar ratio of neocuproine and Cu(II) in the 
reaction mixture (Cu(II) / Nc = 1 / 2.4) was determined in 
the optimization part of the experiment. 
 Three commercially available pharmaceutical prepa-
rations were analyzed in this work: L-glutathione capsules, 
50 mg of GSH (Solaray, Park City, Utah, USA), Metalcaptase 
tablets, 300 mg of PEN (HEYL Chemisch-Pharmazeutische 
Fabrik GmbH & Co. KG, Berlin, Germany) and Captimer tab-
lets, 100 mg of MPG (MIT Gesundheit GmbH, Kleve, 
Germany). The content of ten GSH-containing capsules was 
weighed and mixed. A powder quantity equivalent to 50 mg 
of GSH was dissolved in 500 mL of deionised water. Ten 
PEN-containing tablets, or ten MPG-containing tablets, 
were weighed and pulverized. A powder quantity equiva-
lent to 300 mg of PEN, or 100 mg of MPG, was dissolved in 
300 mL of deionised water, filtered through filter paper 
(Blue ribbon, S&S, Germany), and the filtrate collected in a 
500 mL volumetric flask was diluted by deionised water to 
the nominal volume. After adequate dilution to adjust the 
required concentration, the sample was injected in the FIA 
system. It is noteworthy that such solutions are not stable 
and should be analysed within 24 hours. 
 Iodine, sodium thiosulfate and perchlorate acid solu-
tions were prepared and standardized according to the 
literature for the validation part of the experiment.[7–9]  
Apparatus and Procedure 
A schematic diagram of the FIA manifold used in the pre-
sent work is shown in Figure 1. The FIA manifold was 
previously described in more details.[32] The peristaltic 
pump (Ismatec, Zurich, Switzerland) pumped the reagent 
solution (RS) at 3 mL min–1 and water carrier stream (CS) at 
5 mL min–1 (4 mL min–1for MPG analysis). A rotary valve 
(Rheodyne, Model 5020, Anachem, Luton, UK) was used for 
injecting standard RSH and samples into the carrier stream. 
The reaction was initiated by injection of a standard or sam-
ple solution (500 µL) in the carrier stream forming the sam-
ple zone that flowed to the confluence point (CP), and 
merged with the reagent stream (1.0 × 10–3 mol L–1 
copper(II) and 2.4 × 10–3 mol L–1 neocuproine in Britton-
Robinson buffer, pH = 3). Consequently, the redox reaction 
occurred as the final stream flowed into the reaction coil 
(RC) (length: 40 cm, i.d. 0.8 mm, volume of 200 µL). The 
formed complex reached the flow cell unit (10 mm optical 
path and 160 µL inner volume) where the absorbance  
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ultraviolet-visible spectrophotometer (Shimadzu UV-1601, 
Kyoto, Japan). Using a cycle time of 20 sec, 180 injec-
tions/hour were performed (30 sec and 120 injections/hour 
for MPG). The peak height was employed as the quantita-
tive variable.  
 The pH adjustments and measurements were made 
with a Mettler Toledo SevenMulti potentiometer (Mettler 
Toledo, Schwerzenbach, Switzerland) fitted with a com-
bined glass electrode Mettler Toledo InLab®413. The tem-
perature optimization was carried out in a temperature-
controllable water bath accurate to ± 0.5 °C. 
 
RESULTS AND DISCUSSION 
The proposed method for the determination of RSH is 
based on the redox reaction (Equation 1) in which RSH 
reduce copper(II)-neocuproine complex (Cu(Nc)2+) to a 
yellow-orange copper(I)-neocuproine complex (Cu(Nc)2+), 
having an absorption maximum at λ = 458 nm.[14] Prelimi-
nary batch studies were performed to obtain absorption 
spectra of Cu(II)-neocuproine and Cu(I)-neocuproine com-
plexes and to confirm absence of spectral interferences and 
the kinetic properties.[33]  
 
 2RSH + 2Cu(Nc)22+ ⇌  RSSR + 2Cu(Nc)2+ ‘ 2H+ (1) 
 
Optimization of the Chemical Conditions 
The optimal conditions for pH, concentrations of Cu(II) and 
neocuproine, temperature, and robustness of the redox 
reaction, established in a previous kinetic study[33] were 
confirmed in the present method (Table 1). Reaction rate 
and absorbance did not significantly change with pH over a 
wide range in the first minutes of the reaction. Using the 
FIA manifold, the absorbance was recorded five to ten sec-
onds after beginning of the reaction (depending on the 
manifold parameters). pH value of 3.0 was considered suit-
able and chosen for further experiments, as RSH are more 
stable in acidic media and the selectivity of the reaction is 
higher at lower pH. The redox reaction rate is rapid at room 
temperature, such that small changes in the temperature 
of the reaction mixture had no effect on the reaction kinet-
ics. This independence is advantageous because the flow 
manifold cannot be easy thermostated and despite some 
variability in laboratory temperature, measurements were 
reproducible and precise. 
Optimization of the FIA Conditions 
The main parameters related to the performance of the FIA 
system referring to sample, carrier and reagent flow rates, 
reaction coil length, reagent concentration and sample 
volume were studied and optimized. The values chosen to 
be optimum were those that are the best compromise 
between absorbance signal, repeatability and sample 
throughput (Table 1). 
 The carrier and reagent flow rate were studied by 
varying the rotation speed of peristaltic pump. By 
increasing the flow rate of carrier stream ranging from 0.5 
to 6.0 mL min–1 the signal height increased till the flow rate 
of 4.0 mL min–1 due to the fast chemical reaction. As this 
shortens the reaction time, increases sample throughput 
and decreases the dispersion, the optimum flow rate was 
chosen at higher values shown in Table 1. The flow rate of 
the reagent stream, 3.0 mL min–1, showed the highest 
response for all RSH determinations and this flow rate was 
set as optimal parameter considering low reagent 
consumption. Injected standard volume into carrier stream 
showed an optimum value of 500 µL volume due to the 
maximum absorbance signal and better run-to-run 
reproducibility. For the volumes higher than 500 µL the 
signal needed a longer time to reach the baseline due to 
the time of rinsing which decreased the frequency. 
 The influence of the length of the reaction coil (30, 
40, 50, 60 cm) had little effect on the sensitivity of the 
 
Figure 1. Schematic of the flow injection system:  
P, peristaltic pump; S, sample or standard solution of  
RSH; CS, carrier solution (H2O); RS, reagent solution  
{1.0 × 10–3 mmol L–1 Cu(II) + 2.4 × 10–3 mmol L–1 Nc}, pH = 
3.0; V: six-way injector valve; CP, confluence point; RC, 
reaction coil; FC, spectrophotometric detector equipped 
with flow cell; R, recorder; W, waste. 
 
Table 1. Optimization of manifold conditions and chemical 
parameters for the proposed redox reaction. 
Variable Studied range 
Optimum 
conditions 
GSH PEN MPG 
Wavelength / nm 400–800 458 458 458 
pH 2.0–6.0 3.0 3.0 3.0 
t / °C 20–40 25 25 25 
Molar ratio Cu(II) / Nc 1/1.0–1/3.5 1/2.4 1/2.4 1/2.4 
Carrier stream flow rate /  
mL min−1 
0.5–6.0 5.0 5.0 4.0 
Reagent stream flow rate / 
mL min–1 1.5–6.0 3.0 3.0 3.0 
Injection sample volume / µL 100–1000 500 500 500 
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determination as the reaction rates are high and the 
analytical signals did not vary significantly. The signal 
intensity increased with the increasing mixing coil length up 
to 60 cm. Longer reaction coils (125, 300, 525 cm) gave a 
slight decrease in signal due to the dispersion of the redox 
reaction product. 
Analytical Characteristics of the 
Proposed Method 
Under the selected manifold and chemical conditions the 
proposed flow injection method showed good linear 
response in a concentration range from 2 × 10−6 to  
3 × 10−5 mol L−1 for GSH, 6 × 10−7 to 4 × 10−5 mol L−1 for PEN 
and 4 × 10−7 to 4 × 10−5 mol L−1 for MPG. Limits of detection, 
regression equations with corresponding coefficients, 
relative standard deviation and analytical frequency for the 
studied RSH are shown in Table 2. 
Accuracy 
In order to validate and test the accuracy of the new 
method to determine RSH in pharmaceuticals, the recovery 
studies were performed. Known amounts of RSH standards 
were added to preanalysed pharmaceutical formulation 
prior to analysis by the proposed method. The results 
showed that the recovery of the developed FIA method was 
in the range from 98 % to 103 % (Table 3). This findings 
supported the accuracy of developed method as well as the 
absence of interfering substances in the used samples. 
Interfering Species 
Under the optimized conditions the effect of some sub-
stances that can accompany pharmaceutical formulations 
were studied. The tolerance limit was defined as the ratio 
of the concentration of RSH to foreign species in corre-
spondence of which the added interferences cause a rela-
tive error within ± 5 % for the determination of RSH. The 
influence of mentioned substances did not interfere up to 
500-fold excess for glucose, fructose, lactose, sucrose con-
sidering GSH and MPG as analyte, whereas a 5 times lower 
concentration of same substances did not interfere in case 
of PEN. A 50-fold (PEN) or 100-fold (GSH and MPG) excess 
of sodium citrate dihydrate, citric and tartaric acid did not 
interfere as well despite the acidic interference media. It 
should be noted that the occurrence of interference is 
expected in the presence of substances that are strong 
reducing agents, such as ascorbic acid and other RSH. How-
ever, such reducing agents are not normally included in 
pharmaceutical formulations containing GSH, PEN and MPG. 
 
Table 2. Analytical characteristics of the developed method. 
 GSH PEN MPG 
Linear range / mol L–1 
2 × 10–6– 
3 × 10–5 
6 × 10–7– 
4 × 10–5 
4 × 10–7– 
4 × 10–5 
Regression equation 
y = 3509 x– 
0.0086 
y = 4260 x – 
0.0014 
y = 3727 x + 
0.0008 
LOD / mol L−1 4.1 × 10–7 1.7 × 10–7 1.3 × 10–7 
Correlation coefficient, 
R2 0.9969 0.9993 0.9989 
Relative standard 
deviation, RSD / % 
0.60 0.37 0.24 
Analytical frequency / 
h−1 
180 180 120 
 
 
Table 3. Testing the accuracy of the new method for the 
determination of RSH. 
Added / µg mL–1 Found(a) / µg mL–1 Recovery / % 
L-Glutathione(b) 
0.0 100.3 ± 0.5 − 
50.0 151.2 ± 0.9 101.8 
100.0 202.4 ± 1.3 102.1 
150.0 252.6 ± 1.8 101.5 
200.0 304.9 ± 2.2 102.3 
Metalcaptase(c) 
0.0 100.1± 0.6 − 
50.0 149.1 ± 1.2 98.0 
100.0 199.2 ± 1.5 99.1 
150.0 254.4 ± 2.1 102.8 
200.0 305.3 ± 2.4 102.6 
Captimer(d) 
0.0 100.5 ± 0.3 − 
50.0 151.4 ± 0.8 101.8 
100.0 199.6 ± 1.4 99.1 
150.0 254.3 ± 1.8 102.5 
200.0 304.6 ± 2.3 102.1 
(a) Average of three determinations ± SD. 
(b) Capsules containing GSH 50 mg and excipients. 
(c) Tablets containing PEN 300 mg and excipients. 
(d) Tablets containing MPG 100 mg and excipients. 
 
Table 4. Content of RSH in pharmaceutical formulations 




m / mg 
Official method(a) 
m / mg 
L-Glutathione(b)   50.9 ± 0.8  51.3 ± 0.7 
Metalcaptase(c) 302.3 ± 2.4 301.8 ± 2.5 
Captimer(d) 101.4 ± 1.3 101.8 ± 1.5 
(a) Average of three determinations ± SD. 
(b) Capsules containing GSH 50 mg and excipients. 
(c) Tablets containing PEN 300 mg and excipients. 
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The developed FIA method was applied for the determina-
tion of RSH contents in commercially available pharmaceu-
tical preparations. Official methods from the British 
Pharmacopoeia were used for comparison.[7–9] As MPG is 
an orphan drug and there is no specific assay for MPG de-
scribed in the British Pharmacopoeia, we used the method 
described for measurement of acetylcysteine, a thiol com-
pound with the same molecular weight as MPG, for compar-
ison of the methods. There were no significant differences (P 
> 0.1, Student t-test) between the values obtained by the of-
ficial methods and those obtained by the new method (Table 
4). Therefore, there are clear advantages of the new FIA 
method (wide linearity range, higher sensitivity and 
sampling rate, reduction in both reagent consumption and 
time of analysis) without any reduction in accuracy and pre-
cision, in comparison to the official methods. 
Comparison 
Performance characteristics of the published FIA spectro-
photometric methods for determination of PEN[29,30] and of 
MPG[30,31] in pharmaceuticals, and the new method, are 
compared in Table 5. As we have previously remarked, we 
could not find in the literature any FIA spectrophotometric 
methods for determination of GSH in pharmaceuticals. The 
new FIA method has a few advantages over previously re-
ported methods: wide linear dynamic concentration range 
(almost two decades), higher sensitivity, greater sample 
frequency (120 to 180 analysis per hour) and measurement 
performed in the visible region (λ = 458 nm) - away from 




The present study demonstrates the potential application 
of a simple FIA spectrophotometric method for determina-
tion of glutathione, penicillamine and tiopronin in pharma-
ceutical formulations. The new method is based on a redox 
reaction where the RSH reduces CuII – neocuproine 
complex to CuI – neocuproine complex. It is adequately 
sensitive and accurate to be used for routine quantification 
of RSH without expensive reagents and instruments. 
Advantages of the proposed method over the previously 
published FIA spectrophotometric methods include wide 
linearity range, higher sensitivity and sampling rate. 
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